106 related articles for article (PubMed ID: 11776799)
1. [Clinical study of advanced nasopharyngeal carcinoma treated with radiotherapy combined with DDP and vindesine].
Liu M; Liu H; Mao Z
Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):54-6. PubMed ID: 11776799
[TBL] [Abstract][Full Text] [Related]
2. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
[TBL] [Abstract][Full Text] [Related]
3. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials.
Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Au GK; Min HQ
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1300-6. PubMed ID: 16750333
[TBL] [Abstract][Full Text] [Related]
4. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
[TBL] [Abstract][Full Text] [Related]
5. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china.
Chen Y; Liu MZ; Liang SB; Zong JF; Mao YP; Tang LL; Guo Y; Lin AH; Zeng XF; Ma J
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1356-64. PubMed ID: 18472356
[TBL] [Abstract][Full Text] [Related]
6. [Radiotherapy with concurrent chemotherapy for treatment of advanced nasopharyngeal carcinoma].
Feng ZF; Pan HL; Song HS; Liu ZM; Huang Y
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jun; 24(6):694-6. PubMed ID: 15201093
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials.
Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Min HQ
J Clin Oncol; 2005 Feb; 23(6):1118-24. PubMed ID: 15657403
[TBL] [Abstract][Full Text] [Related]
8. [The long-term therapeutic results of chemotherapy combined with radiotherapy in advanced nasopharyngeal carcinoma].
Gu Z; Wei Q; Huang K
Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):392-4. PubMed ID: 10920926
[TBL] [Abstract][Full Text] [Related]
9. Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma.
Pan JJ; Zhang SW; Chen CB; Xiao SW; Sun Y; Liu CQ; Su X; Li DM; Xu G; Xu B; Lu YY
J Clin Oncol; 2009 Feb; 27(5):799-804. PubMed ID: 19103729
[TBL] [Abstract][Full Text] [Related]
10. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group.
Lee AW; Lau WH; Tung SY; Chua DT; Chappell R; Xu L; Siu L; Sze WM; Leung TW; Sham JS; Ngan RK; Law SC; Yau TK; Au JS; O'Sullivan B; Pang ES; O SK; Au GK; Lau JT;
J Clin Oncol; 2005 Oct; 23(28):6966-75. PubMed ID: 16192584
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety.
Wee J; Tan EH; Tai BC; Wong HB; Leong SS; Tan T; Chua ET; Yang E; Lee KM; Fong KW; Tan HS; Lee KS; Loong S; Sethi V; Chua EJ; Machin D
J Clin Oncol; 2005 Sep; 23(27):6730-8. PubMed ID: 16170180
[TBL] [Abstract][Full Text] [Related]
12. Toxicity and feasibility analysis for cisplatin-based concomitant chemoradiotherapy in locally advanced nasopharyngeal carcinoma.
Atasoy BM; Dane F; Yumuk PF; Akgün Z; Turhal NS; Abacioğlu U; Sengöz M
J BUON; 2008; 13(1):43-50. PubMed ID: 18404785
[TBL] [Abstract][Full Text] [Related]
13. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma.
Chua DT; Sham JS; Au GK
Head Neck; 2004 Feb; 26(2):118-26. PubMed ID: 14762880
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
15. Patterns of failure following radiation with and without chemotherapy in patients with nasopharyngeal carcinoma.
Fuchs S; Rödel C; Brunner T; Iro H; Niedobitek G; Sauer R; Grabenbauer GG
Onkologie; 2003 Feb; 26(1):12-8. PubMed ID: 12624512
[TBL] [Abstract][Full Text] [Related]
16. Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study.
Kwong DL; Sham JS; Au GK; Chua DT; Kwong PW; Cheng AC; Wu PM; Law MW; Kwok CC; Yau CC; Wan KY; Chan RT; Choy DD
J Clin Oncol; 2004 Jul; 22(13):2643-53. PubMed ID: 15226332
[TBL] [Abstract][Full Text] [Related]
17. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
Chan SH; Ng WT; Kam KL; Lee MC; Choi CW; Yau TK; Lee AW; Chow SK
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1335-42. PubMed ID: 18922648
[TBL] [Abstract][Full Text] [Related]
18. Locoregionally advanced nasopharyngeal carcinoma: induction chemotherapy with cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin: a phase II study.
Ferrari D; Chiesa F; Codecà C; Calabrese L; Jereczek-Fossa BA; Alterio D; Fiore J; Luciani A; Floriani I; Orecchia R; Foa P
Oncology; 2008; 74(3-4):158-66. PubMed ID: 18714164
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy.
Chua DT; Nicholls JM; Sham JS; Au GK
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):11-20. PubMed ID: 15093894
[TBL] [Abstract][Full Text] [Related]
20. A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma.
Hareyama M; Sakata K; Shirato H; Nishioka T; Nishio M; Suzuki K; Saitoh A; Oouchi A; Fukuda S; Himi T
Cancer; 2002 Apr; 94(8):2217-23. PubMed ID: 12001120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]